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Abstract
Pseudorabies virus (PRV) initially replicates in the porcine upper respiratory tract. It easily invades the mucosae and
submucosae for subsequent spread throughout the body via blood vessels and nervous system. In this context, PRV
developed ingenious processes to overcome different barriers such as epithelial cells and the basement membrane. Another
important but often overlooked barrier is the substantial mucus layer which coats the mucosae. However, little is known
about how PRV particles interact with porcine respiratory mucus. We therefore measured the barrier properties of porcine
tracheal respiratory mucus, and investigated the mobility of nanoparticles including PRV in this mucus. We developed an
in vitro model utilizing single particle tracking microscopy. Firstly, the mucus pore size was evaluated with polyethylene
glycol coupled (PEGylated) nanoparticles and atomic force microscope. Secondly, the mobility of PRV in porcine tracheal
respiratory mucus was examined and compared with that of negative, positive and PEGylated nanoparticles. The pore size
of porcine tracheal respiratory mucus ranged from 80 to 1500 nm, with an average diameter of 4556240 nm. PRV (zeta
potential: 231.861.5 mV) experienced a severe obstruction in porcine tracheal respiratory mucus, diffusing 59-fold more
slowly than in water. Similarly, the highly negatively (249.860.6 mV) and positively (36.761.1 mV) charged nanoparticles
were significantly trapped. In contrast, the nearly neutral, hydrophilic PEGylated nanoparticles (29.660.8 mV) diffused
rapidly, with the majority of particles moving 50-fold faster than PRV. The mobility of the particles measured was found to
be related but not correlated to their surface charge. Furthermore, PEGylated PRV (-13.860.9 mV) was observed to diffuse
13-fold faster than native PRV. These findings clearly show that the mobility of PRV was significantly hindered in porcine
tracheal respiratory mucus, and that the obstruction of PRV was due to complex mucoadhesive interactions including
charge interactions rather than size exclusion.
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Introduction
Herpesviruses are double-stranded DNA viruses with the
potential to cause severe diseases in different species. Many
members of the subfamily Alphaherpesvirinae initially replicate in the
epithelial cells of the respiratory and/or genital mucosae [1–3]. An
important member is Pseudorabies Virus (PRV), the prototype
veterinary alphaherpesvirus. PRV causes respiratory tract prob-
lems, nervous system disorders and abortions in pigs. After local
replication in the epithelial cells, these viruses gain access to the
connective tissue and find their way to blood vessels and nerve
endings for spread throughout the host [4–7]. Different important
barriers of the host try to hamper PRV invasion. Recently, it has
been shown that in order to invade, different alphaherpesviruses
including PRV use proper processes to pass an important barrier
underneath the epithelium, the basement membrane [2,8,9].
Importantly, prior to epithelial cell entry, a mucus layer that coats
the epithelium and serves as the first line of defense, has to be
overcome by the virus [10].
Mucus is a viscoelastic and adhesive gel that coats the non-
keratinized epithelial surface of different mucosae. The thickness
of the mucus layer varies among different types and species,
ranging from several to more than 100 microns for the trachea of
different animals [11–13]. Next to serving as a lubricant and
assisting the adsorption of nutrients, the mucus layer acts as the
body’s first barrier against microbial infections. The major
component and property determinant are heavily glycosylated
glycoproteins, known as mucins. The assembly of these mucins in
fiber structures creates an entangled mucus meshwork [14,15].
The mesh (pore) size sets a threshold beyond which particle
diffusion is hindered: particles with diameters larger than this mesh
size are rejected while smaller, minimally interactive particles
should pass through the mucus. However, in addition to this size
filtering mechanism, mucus seems to use more sophisticated
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strategies to interact with the traversing particles, especially diverse
viruses that attempt to invade the body through the mucosae.
Olmsted et al. [16] reported that two capsid virus-like particles,
human papillomavirus (diameter 55 nm) and Norwalk virus
(38 nm), diffused rapidly in human cervicovaginal mucus, because
of the neutral charge of viral capsids and probably also due to the
size. It is hypothesized that small particles expose less hydrophobic
patches, and are therefore limited in making polyvalent bonds with
the hydrophobic domains distributed along the mucin fibers.
However, Hida and colleagues described an even smaller capsid
virus, adeno-associated virus serotype 5 (20 nm), to be highly
trapped in human cystic fibrosis sputum of which the pore size
ranged from 60 to 300 nm [17]. To date, the motion of different
viruses ranging from large enveloped viruses, such as herpes
simplex virus [18] and human immunodeficiency virus (HIV) [19],
to small non-enveloped viruses, such as adenovirus [17], human
papillomavirus and adeno-associated virus, have been investigated
in mucus. However, these studies were limited to human
cervicovaginal mucus and human cystic fibrosis sputum because
none of the other types of mucus were readily available.
Particularly, the interaction of aerosol respiratory viruses with
healthy respiratory mucus has never been studied. Unraveling the
mechanism behind the penetration of viruses across the mucosal
barriers has potentially significant implications for the develop-
ment of novel antiviral strategies. To achieve a better understand-
ing in this matter, an in vitro model resembling the in vivo situation
is needed. As PRV is commonly used as a good model for human
alphaherpesviruses, it is highly interesting to investigate how PRV
interacts with porcine respiratory mucus. Therefore, the main
objectives of this study were to fully characterize the filtering
properties of porcine respiratory mucus to nanoparticulate
systems, and to better understand the interactions between PRV
and the mucus through which it invades in an attempt to unravel
the mechanism of how PRV penetrates through porcine respira-
tory mucus.
In order to measure the microstructure of porcine respiratory
mucus, atomic force microscopy (AFM), a high-resolution imaging
technique, was used to visualize the surface of the mucus samples
and to measure the pore size formed by the mucus elements. It
enables to measure the forces acting between a sample and a fine
tip, which is attached to the free end of a cantilever and brought
very close to the surface. Attractive or repulsive forces resulting
from interactions between the tip and the surface can lead to a
deflection of the cantilever according to Hooke’s law [20,21]. As
such, a three-dimensional image of the sample surface can be
obtained and the pore size can be measured with the line profiling
feature of the AFM software. Additionally, the effective pore size
of porcine tracheal respiratory mucus was further evaluated by
analyzing the motion of polyethylene glycol (PEG) coupled, non-
adhesive nanoparticles in function of particle size. Based on the
theory that particle transport in heterogeneous environments is
regulated by the local properties of the material, non-adhesive
particles smaller than the effective mesh spacing (pore size) of the
network are capable of diffusion because they tend to experience
the lower viscosity of the interstitial space [22,23].
In this study, we have developed a model to study the virus-
mucus interactions and demonstrated the mucoadhesive influence
of porcine respiratory mucus on the mobility of PRV. We have
implied single particle tracking (SPT) microscopy, which uses high
speed video microscopy to track the diffusion of hundreds of
particles simultaneously and analyzes the motion of particles.
Particle trajectories are used to calculate time-averaged mean
squared displacements (MSD) and to determine time-dependent
diffusion coefficients, which are subsequently used to characterize
individual particle transport modes [24]. Utilizing the technique,
we analyzed the microstructure of the porcine tracheal respiratory
mucus, and detected the mobility of PRV and different charge
modified nanoparticles in the mucus.
Materials and Methods
Mucus Sampling and Preparation
Tracheal respiratory mucus was collected from porcine tracheas
within 3 h after slaughter. Porcine tracheas were obtained with the
permission of and collected from G. Van Landschoot & Zonen
N.V., Adegem, Belgium (a local slaughterhouse) and stored on ice
prior to mucus collection. The trachea was isolated and cut open
longitudinally. Mucus was gently scraped with a spoon, collected
with a syringe, and stored at –70uC until use.
Atomic Force Microscopy
Porcine tracheal respiratory mucus (100 ml) was evenly coated
on glass (1 cm2) and was air-dried at room temperature, according
to the protocol adapted from Broughton-Head et al. [25]. Atomic
force microscopy (AFM) images were obtained in ambient
conditions in air using a multimode scanning probe microscope
(Digital Instruments, Santa Barbara, CA, USA) equipped with a
Nanoscope IIIa controller. 5 mm65 mm scans were recorded in
tapping mode using a silicon cantilever (OTESPA, Veeco, CA,
USA). Pore diameters were obtained using the line profiling
feature of the AFM software (NanoScope software version 4.43r8,
Veeco Instruments, USA).
Preparation and Characterization of Nanoparticles
Negatively charged, yellow-green fluorescent carboxylate-mod-
ified FluoSpheresH of different diameters, 100 nm, 200 nm and
500 nm, were purchased from Invitrogen (Merelbeke, Belgium).
According to the protocol of Symens et al. [26], positively charged
nanoparticles were obtained as a result of amide formation
between the carboxylate groups of the carboxylate modified
FluoSpheresH and the primary amine group of N, N-dimethy-
lethylenediamine. PEGylated nanoparticles were prepared by
covalent modification of the surface carboxylate groups of
carboxylate modified FluoSpheresH with methoxy-polyethylene
glycol-amine (mPEGa, 2 kD, Creative PEGWorks, Winston
Salem, USA.) as previously described [27]. Particle size (diameter)
and surface charge (zeta potential) were determined by dynamic
light scattering and laser Doppler anemometry, respectively, using
the Zetaziser Nano-ZS (Malvern, Worcestershire, UK).
PEGylation of PRV
The recombinant PRV Becker strain expressing green fluores-
cent protein fused to the VP26 capsid protein was a kind gift of Dr.
Greg Smith (Northwestern University, Chicago, IL, USA). The
PRV stock (108.0 TCID50/ml) was concentrated by ultracentrifu-
gation at 80 000 g for 90 min at 4uC in a Type 35 rotor (Beckman,
Fullerton, CA, USA). The pellet was resuspended in phosphate
buffered saline (PBS: 137 mM NaCl, 10 mM Na2HPO4, 2.7 mM
KCl, 2 mM KH2PO4, pH 7.4), loaded upon a 30% sucrose
cushion and followed by ultracentrifugation at 100 000 g for 3 h at
4uC in an SW41Ti rotor (Beckman, Fullerton, CA, USA). The
virus pellet was resuspended in PBS to give an approximate
concentration of 1010 TCID50/ml. Methoxy-polyethylene glycol
activated by succinimidyl succinate (mPEG-NHS, 2 kD) (NAN-
COS, Huissen, Netherlands) was added to the virus suspension,
giving a final concentration of 20 mg/ml. The coupling reaction
was performed for 2 h at 25uC. Afterwards, unreacted mPEG-
NHS and the byproducts were removed by buffer exchange over a
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centrifugal filter (50 K membrane, Millipore). The size and zeta (f)
potential of the PEGylated PRV were measured with the Zetaziser
Nano-ZS (Malvern) and the PEGylated PRV was preserved at 4uC
until use.
Real-time Single Particle Tracking
The trajectories of fluorescent particles in porcine tracheal
respiratory mucus were recorded by a fast and sensitive electron-
multiplying charge-coupled device (EMCCD) camera (Cascade II:
512; Roper Scientific, Tucson, AZ, USA) mounted on an inverted
epifluorescence microscope (Nikon TE2000E, Nikon Belux,
Brussels, Belgium) equipped with a 1006 oil-immersion objective
(Plan Apochromat, Nikon). Tracking experiments were performed
in press-to-sealTM silicone isolators (20 mm diameter, 0.5 mm
deep, Invitrogen, Merelbeke, Belgium). Three microliters of virus
suspension (1010 TCID50/ml) or nanoparticles (0.004 wt.-%) were
mixed with 100 ml porcine tracheal respiratory mucus by gentle
stirring to avoid perturbation. The movies were captured with the
NIS Elements AR software (Nikon) at a temporal resolution of
46.2 ms for 5 s. The illumination time was 10 ms per frame.
Trajectories of n $500 particles were analyzed for each
experiment and at least three independent experiments were
performed for each condition. Movies were analyzed with the
Image Processing Software (IPS, in-house developed software) to
extract x, y positional data over time. The time-averaged mean
squared displacements (MSD) and apparent diffusion coefficient
(Da) were calculated as a function of the time scale (t) for each
particle.
Data Analysis
Analysis of the movies was performed with custom made image
processing software [28]. Individual particles were identified in
each frame of a movie and their centroids were calculated. The
trajectories of the particles were determined by a nearest neighbor
algorithm. For each trajectory, the mean squared displacement
(MSD) was calculated for the available time lags t (i.e. multiples of
the time Dt between the images). The MSD versus t plots were
analyzed by a weighted fit of the anomalous diffusion model
[29,30]: MSD=Cta, with the transport coefficient C and the
anomalous exponent a as free fitting parameters. The value of a is
a measure for the mode of diffusion: for free diffusion a=1 (C
becomes equal to 4 times the diffusion coefficient), while a ,1
indicates hindered diffusion. The deviation of a from 1 is thus a
measure for the anomaly of the diffusion. By analyzing the
trajectories according to this anomalous diffusion model, distribu-
tions of the corresponding a-values can be obtained. Besides this,
the apparent diffusion coefficient Da corresponding to the first time
lag Dt was calculated according to the classical expression:
Da=MSD/4Dt [30].
Note that in the case of free diffusion, Da reduces to the diffusion
coefficient. Distributions of the apparent diffusion coefficient can
be obtained by analyzing the trajectories of the particles. These
distributions are further refined with a maximum entropy method
(MEM) [28]. The MEM analysis improves the precision of the
distributions, and removes features that are not statistically
warranted by the data.
Results
Microstructure of Porcine Tracheal Respiratory Mucus
The porous nature of porcine tracheal respiratory mucus was
visualized using TappingMode AFM. The color intensity shows
the vertical profile of the sample surface, with light regions
representing the highest points and the dark points representing
the depressions and pores (Figure 1A). Pore diameters were
measured with the line profiling feature of the AFM software.
Distribution of the pore diameters (n = 500) obtained from three
independent experiments illustrated that the pore size of the
porcine tracheal respiratory mucus was highly various, ranging
between 80 and 1500 nm. The average pore size was
4556240 nm in diameter, with 85% of the pores being larger
than the diameter of PRV particles (Figure 1B). To further
evaluate the effective mesh spacing of porcine tracheal respiratory
mucus, translocations of 100, 200, and 500 nm PEGylated muco-
innert nanoparticles, were tracked and transport rates were
analyzed. The MSD of the nanoparticles was fitted to the equation
MSD=CDta to obtain a, an indicator of the extent of particle
impediment. After PEGylation, the nanoparticles were slightly
enlarged in diameter due to the coverage with PEG. The nearly
neutral surface charge suggested that the PEGylation of the
particles was complete (Table 1). As demonstrated in Figure 1C,
most of 100 nm and 200 nm PEGylated nanoparticles diffused
freely through mucus, whereas, part of the 500 nm PEGylated
nanoparticles were subdiffusive. This partially hindered motion is
also apparent from the bimodality of the distribution of diffusion
coefficient for the 500 nm nanoparticles (Figure 1D).
PRV was Highly Obstructed in Porcine Tracheal
Respiratory Mucus
The motion of PRV (245.7611.5 nm) in porcine tracheal
respiratory mucus or in water was investigated and compared with
those of 200 nm PEGylated nanoparticles. PRV was greatly
slowed down in mucus with respect to the PEGylated particles. At
the time scale of 1 s, the ensemble mean squared displacement
,MSD. of the PEGylated nanoparticles was 160-fold higher than
that of PRV (Figure 2A). Trajectories of 10 steps have been
analyzed, from which a distribution of the apparent diffusion
coefficients was obtained (Figure 2B). This clearly demonstrates
that PRV experienced a severe obstruction in porcine tracheal
respiratory mucus, with the majority of virus particles diffusing 50-
fold slower than PEGylated nanoparticles. Similarly, an average a
value of 0.17 was observed for PRV compared to 0.86 for the
200 nm PEGylated nanoparticles. PEGylated nanoparticles thus
freely diffused through the porcine tracheal respiratory mucus
whereas PRV was significantly immobilized.
Particle Surface Charge and Particle Mobility
To determine the relationship between surface charge and
particle mobility, the diffusion of strongly negatively and positively
charged nanoparticles, the nearly neutral, hydrophilic PEGylated
nanoparticles (200 nm) and PRV were measured in mucus.
Indicated by the representative trajectories (Figure 3B), the
diffusive motion of the strongly charged nanoparticles and PRV
was highly obstructed. In contrast, PEGylated nanoparticles were
allowed to diffuse rapidly. PEGylated nanoparticles diffused 30-
fold faster than PRV in mucus and more than 15 and 17-fold
faster than the positive and negative nanoparticles, respectively
(Figure 3C). These data suggest that the surface charge was
involved in the interactions between particles and the mucus
environments, which further affected the particle mobility.
However, PRV clearly diffused more slowly than the higher
negatively charged nanoparticles implying that other types of
interactions may also play a role in this case.
PRV Mobility was Increased by PEGylation
The PEGylated PRV was less adhesive to porcine tracheal
respiratory mucus than the native PRV. After PEGylation, the
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diameter of PEGylated PRV was slightly greater than the
uncoated virus. f potential analysis revealed that the surface
charge was altered from 231.861.5 mV to 213.860.9 mV after
PEGylation. The transport rate of PEGylated PRV was 11-fold
higher than PRV (Table 2). Taken together, the mobility of PRV
in porcine tracheal respiratory mucus was increased by coating
uncharged, hydrophilic PEG onto its surface.
Discussion
PRV, often used as a representative for alphaherpesviruses,
initially infects the porcine upper respiratory tract. In order to
unravel the invasion of PRV through the mucus layer, we have set
up an in vitro model of porcine tracheal respiratory mucus and
analyzed the mobility of PRV through it.
In the first part, AFM was used to visualize and measure the
pore diameter in porcine tracheal respiratory mucus. AFM has
several advantages over electron microscopy. Firstly, analysis of
the cantilever deflections enables the calculation of all three
dimensions of the currently analyzed feature of the specimen, e.g.
width, length and height. As a result, three-dimensional images are
generated [31]. Secondly, samples viewed by AFM do not require
special treatments such as fixation and metal coating that would
irreversibly change or damage the samples. Thirdly, when imaging
a dried sample deposited on a glass surface instead of a hydrated
sample, the mucus polymers are immobilized, and the resolution is
improved [32,33]. Using this technique, we demonstrated that the
mesh size of porcine tracheal respiratory mucus was highly
heterogeneous, ranging from 80 nm to 1500 nm. Furthermore,
PEGylated nanoparticles are minimally interactive with mucus
and therefore are an ideal approach to probe the mucus
microscopic structure. The dense PEG shielding is able to provide
nanoparticles with highly hydrophilic surface properties, resulting
in less hydrophobic patches subjected to mucoadhesion as well as
less capability of ionic bonding due to the nearly uncharged
surface (PEG is nonionic at physiological pH values). The
hindered motion of the 500 nm PEGylated nanoparticles suggest-
Figure 1. Evaluation of the microstructure of porcine tracheal respiratory mucus. (A) AFM visualization (5 mm65 mm) of porcine tracheal
respiratory mucus. (B) Pore size distribution of the porcine tracheal respiratory mucus as measured by AFM. Pore diameters were analyzed by the line
profiling of the 3-D images. Three scans were performed for each sample, and three independent samples were measured. The dashed line indicates
the average of pore diameters (n = 500). (C) Transport modes of 100, 200 and 500 nm PEGylated nanoparticles indicated by a value. More than 2000
trajectories from 3 independent experiments were tested to obtain a. (D) Distributions of the apparent diffusion coefficient of PEGylated
nanoparticles. Trajectories of 10 steps were analyzed for each of the 2000 diffusion coefficients. Distributions were refined with MEM.
doi:10.1371/journal.pone.0051054.g001
Table 1. Surface charge and size of the PEGylated
nanoparticles.
Size f potential (mV) Diameter (nm)
100 nm* 28.760.5 124.660.5
200 nm* 29.660.8 232.662.4
500 nm* 29.360.9 538.067.5
*Provided by the manufacture.
doi:10.1371/journal.pone.0051054.t001
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ed that these particles were probably obstructed by the mesh. This
also fits the pore size estimation by AFM. Unlike mucus, the range
of the pore size of the collagen-laminin network in the basement
membrane is much smaller, approximately 50–100 nm [34–36].
Only small particles are able to diffuse across such pores. Passage
of microorganisms through this barrier often involves regulatory
protease breakdown of the collagen-laminin network. Thus the
basement membrane clearly warrants a potent physical barrier
against pathogenic invasion and passage of microorganisms. As the
mucus pore size is tremendously heterogeneous, and most of the
pores are larger than the diameter of viruses, it would be risky if
the mucus exclusively relies on a size exclusion mechanism to repel
the potentially invading viruses. Instead, alternative filtering
mechanisms may be employed.
In the second part, we analyzed the mobility of negative,
positive and PEGylated nanoparticles in porcine tracheal respira-
tory mucus and compared this to the motion characteristics of
PRV. Mucin content, governed by mucin secretion rates as well as
the degree of mucus hydration, is a major determinant of mucus
rheology. Small differences in the concentrations of mucins may
be sufficient to cause significant changes in the mucus viscoelas-
ticity [37,38]. Therefore, to retain the rheological properties of
mucus, a small volume of PRV or nanoparticle suspension was
mixed with porcine tracheal respiratory mucus. At the time scale
of 1 s, PRV (231.861.5 mV, 245.7611.5 nm) experienced a
significant obstruction in porcine tracheal respiratory mucus, with
approximately 96% of the population exhibiting subdiffusive
transport. The slightly smaller PEGylated nanoparticles
(9.660.8 mV, 232.662.4 nm) exhibited a 160-fold higher
,MSD. than PRV at the time scale of 1 s (Figure 2A). Our
results indicate that the immobility of PRV in porcine tracheal
respiratory mucus cannot be explained by a size filtering
mechanism. Instead, a complex interplay of mucoadhesive
interactions is proposed to fully explain this issue. Therefore, the
mobility of positively charged and negatively charged nanoparti-
cles, nearly neutral PEGylated nanoparticles and PRV was
measured. The strongly charged nanoparticles and PRV were
significantly trapped in porcine tracheal respiratory mucus,
whereas relatively neutral PEGylated nanoparticles were diffusive,
implying the role of electrostatic forces in the interactions between
mucus and particles. Similarly, Lieleg et al. [39] analyzed the
diffusions of amine-, carboxyl-terminated and PEGylated particles
(1 mm) in extracellular matrix (ECM) purified from the Engel-
breth-Holm-Swarm sarcoma of mice, and found that the diffusion
of charged particles was extremely suppressed compared to the
neutral PEG modified particles, indicating particle mobility was
related to the surface charge. Moreover, it is reported that the
higher the surface potential of amine-terminated particles, the
stronger the particle mobility was suppressed in porcine gastric
mucin, and that a high salt concentration could increase the
mobility of amine-terminated particles by shielding the surface of
particles with counter ions [40]. Our findings suggest that charged
Figure 2. Transport rates of PRV and 200 nm PEGylated nanoparticles in porcine tracheal respiratory mucus or in water. (A)
Averaged ensemble mean squared displacements,MSD. of PRV and 200 nm PEGylated nanoparticles with respect to time scale. Error bars indicate
standard errors of the mean. (B) Distributions of the apparent diffusion coefficient of PRV and 200 nm PEGylated nanoparticles. Trajectories of 10
steps were analyzed for each of the 2000 diffusion coefficients. Distributions were refined with MEM. (C) Ratios of the average diffusion coefficients in
mucus (Dm) to those in water (Dw). Three independent experiments were performed for each condition. Error bars indicate the standard deviation.
The asterisk (*) indicates statistical significance (P,0.005).
doi:10.1371/journal.pone.0051054.g002
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particles interacted with the mucin polymers via electrostatic
forces, and these interactions may reduce particle mobility.
Furthermore, the non-glycosylated protein regions may provide
a sufficiently hydrophobic region for adequate particle-mucin
interactions (Figure 4). This is supported by an investigation of the
translocation of modified polystyrene microspheres in gastrointes-
tinal mucin, in which the least hydrophobic amidine-terminated
microspheres were found to have the highest diffusion among the
microspheres [41]. In addition, the envelope of PRV and
hydrophobic domains on its glycoproteins may be subjected to
the hydrophobic cysteine-rich domains along mucin fibers,
forming multiple low-affinity bonds. Although their low-affinity
bonds have short half-lives and are easily broken by thermal
energy [42], a great number of such bonds can keep virus particles
attached to mucin fibers and entrap them. Lastly, hydrogen
bonding appears to play a crucial role in mucoadhesion and
disruption of hydrogen bonds can substantially reduce the
adhesive strength of a mucoadhesive system. Previous studies
showed that the addition of hydrogen bond breaking agents, such
as urea and potassium thiocyanate (KCNS), to porcine gastric
Figure 3. Particle surface charge and particle mobility. (A) f potentials for the particles measured with laser Doppler anemometry. (B)
Representative trajectories of PRV and 200 nm nanoparticles with different surface charge modifications. The diffusions of negatively and positively
charged nanoparticles and PRV were significantly suppressed; the PEGylated nanoparticles diffused rapidly. (C) Diffusion coefficient of the PRV and
modified nanoparticles. Apparent diffusion coefficients Da were determined by particle tracking for ensembles of 2000 particles for each condition.
Error bars indicate the standard error of the mean.
doi:10.1371/journal.pone.0051054.g003
Table 2. Diffusion comparison of PRV and PEGylated PRV.
Particles a Diameter (nm) f potential (mV) Da (mm
2/s) Dm/Dw
PRV 0.167 245.7611.5 231.861.5 0.02360.061 0.01760.004
PEGylated PRV 0.591 269.4616.3 213.860.9 0.28960.779 0.21260.182
doi:10.1371/journal.pone.0051054.t002
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homogenized mucus resulted in a reduction in the elastic (G’) and
viscous (G’’) values [43] and that amylose gel strength could be
significantly reduced by the addition of urea [44]. Interestingly,
mucins contain a high density of negatively charged glycoproteins
that present both strong proton acceptor and donor functionalities
which mediate hydrogen bonding [45]. We thus hypothesize that
sialic acid and sulphate residues on the oligosaccharide chains of
the mucin glycoproteins (Figure 4) are likely to form hydrogen
bonds with the glycoproteins of entrapped PRV particles.
Therefore, investigating the influence of sialic acid and sulphate
residues of porcine respiratory mucins on the mobility of PRV
could help to further unravel the interplay between PRV particles
and the mucus barrier.
In the third part, we modified the surface of PRV particles by
PEGylation and measured the mobility of the resulting virus
particles. Lysine, one of the most prevalent amino acids in
proteins, is known as an ideal target for PEGylation. The NHS
esters of mPEG-NHS react with the primary amine groups of
lysine to form stable amide bonds. Lysine mediated PEGylation of
adenoviruses [46] and vesicular stomatitis virus G pseudotyped
lentivirus vectors [47] have been described to sufficiently shield the
viral surface and to protect the viruses from immune responses. In
our study, attachment of mPEG-NHS to the PRV surface
significantly increased the mobility of the PEGylated PRV. After
PEGylation, the virus still possessed a net surface charge of
213.860.9 mV (Table 2), thus implying that besides highly
reduced charge-charge interactions, other important interactions
may be abolished. The coverage of the surface of virus/
nanoparticles with uncharged, hydrophilic PEG did not only
neutralize the charges which mediates electrostatic interactions,
but also shielded the hydrophobicity and capability of hydrogen
bonding. Hence, PEGylation could turn the ‘‘active’’ PRV into
more ‘‘inert’’ particles.
Alternatively, PRV may bind directly to specific components of
the respiratory mucus. It is known for PRV that heparan sulfate
acts as a cellular receptor for viral attachment and subsequent
entry [48,49]. In addition to the cell surface heparan sulfate,
secretory heparan sulfate may be present as one of the major
proteoglycans in the airway secretions [50,51]. These heparan
sulfates in different forms might function as a ‘‘captor’’ for PRV.
We thus conducted experiments using polyclonal antibodies
(hyperimmune serum) to determine if the entrapment of PRV in
the porcine tracheal respiratory mucus could be mediated by
binding to heparan sulfate (data not shown). Although it is not
known if the PRV glycoprotein C (gC) was fully blocked, we
assume this glycoprotein, responsible for heparan sulfate binding,
to be blocked by the polyclonal antibodies. However, the transport
rate of the neutralized PRV was nearly the same as that of the
natural virus, implying that other interactions rather than specific
PRV-receptor binding may play a determinant role in such virus-
mucus interactions. Furthermore, to determine if mucins may bind
PRV, we performed immunofluorescent stainings using MUC5AC
antibodies that recognize the protein backbone of the mucin
glycoproteins and PRV gC monoclonal antibodies (data not
shown). Attachment of PRV to the mucin network was observed,
but no colocalization was seen, suggesting that the virus did not
bind to the protein backbones of the mucins. Therefore, it would
be interesting to investigate if the sugar side chains of mucins can
be a target.
Our findings have clearly shown that porcine tracheal
respiratory mucus is able to act as a barrier against PRV infection.
This might explain in part the pathogenesis of PRV, as no signs of
viral replication are found in the trachea in vivo. Next to that, our
laboratory used in vitro models of respiratory mucosae of different
parts of the respiratory tract to study the invasion of different
viruses through mucosal surfaces. When applying PRV on porcine
tracheal mucosae, we found that PRV was able to strongly
replicate in the epithelium and even to breach the basement
membrane to infiltrate the host (Steukers et al., unpublished data).
As these tissues were washed several times before inoculation with
a virus, little mucus remained as a coating on the surface. These
latter findings put strength to our hypothesis that porcine tracheal
respiratory mucus might be responsible for protection against
PRV infection in the proximal trachea. It would therefore be
highly interesting to analyze the barrier properties of porcine nasal
respiratory mucus against PRV and compare this to the results
presented in this study. A comparison can also be made with
another alphaherpesvirus in bovine. Similar as for PRV, bovine
herpesvirus 1 (BoHV-1) replicates in the upper respiratory tract.
However, this is not limited to nasal mucosae as BoHV-1 strongly
replicates in the proximal trachea as well. This is confirmed by a
study performed in our lab by using bovine respiratory mucosal
Figure 4. Schematic structure of mucin glycoproteins and their potentially mucoadhesive elements.
doi:10.1371/journal.pone.0051054.g004
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explant models which show that different upper respiratory tissues
are susceptible to BoHV-1 infections [2]. Extrapolation of our
hypothesis for PRV to BoHV-1, suggests that bovine tracheal
respiratory mucus might not have similar protective characteristics
as the porcine counterpart and that this might be a matter of virus-
host co-evolution. Further investigation on this matter might
provide us some crucial information on the invasion capacities of
different alphaherpesviruses through the mucus barrier. Addition-
ally, an important aspect of mucus is that the gel phase mucus is a
discontinuous layer. This is due to the fact that the mucus does not
flow evenly but preferentially concentrates along troughs or
grooves [52]. The thickness of rat tracheal mucus observed with
light- and transmission electron microscopy ranged between 0.1
and 50 mm [11], indicating there were thin or even ‘‘bare’’ regions
that may be more susceptible to viral insult. This might also
explain why certain regions are more susceptible to PRV infection
in the explant model. To fully illustrate this issue, further
investigation will be needed.
In summary, we applied single particle tracking to study particle
diffusion in porcine tracheal respiratory mucus, and developed an
in vitro model to analyze the mobility of PRV in the mucus. We
found that PRV was significantly trapped in porcine tracheal
respiratory mucus, due to complex mucoadhesive interactions.
Thus, mucoadhesion may play a significant role in the host
defense. This model may be a useful tool in revealing the invasion
mechanisms of alphaherpesviruses and in providing some novel
insights into the strategies of mucosal immunity.
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